Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game.
Register for FREE Now
Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
86DA
Posted in: MTFB.L
Posts: 302
Price: 8.85
No Opinion
Smaller Companies seem to get more CRL's, it may be that they present the information in a different way to larger companies who can have a bigger workforce.
Price: 8.89
Are they all nominally 1p shares when issued, presumably they would be linked to the open market share price when they are issued.The placing last year at 30p ish were 1p shares.
Price: 8.40
Buy
From the other Forum, hope it works.https://smithonstocks.com/antares-pharma-approval-of-xyosted-on-or-before-september-29-2018-is-highly-probable-atrs-buy-2-12/Replied after 7 days, went on to be approved.
There have been cases in the past where the FDA have come back before 30 days, which may catch some people out.
Price: 6.55
AMP rns of 19th March said they had 20 million shares left, AMP rns of 1st April says they have 18 million shares left.Only told us about selling 5 million. 2 million shares unaccounted for.I assume they sold those into the spike & wont sell anymore at the moment, i could be wrong.Crappy RNS because it should be clear.
Strong Buy
Yes hopefully they will try to hang on to whats left,
Sold 1,825,000 15th March 2019Sold 3,250,000 19th March 2019
Price: 6.60
My average was 34p, now 21.5p. I do think it will easily get back to 25p.
Price: 10.14
AMP are selling 11m shares all together.Will have 14 million left , being forced by the lender presumably. They may have sold the rest today, as they only expected to get 6p per share.
Price: 5.86
Didn't we all think in Jan/Feb it would get approved.Its all a guess, at the end of the day.
Price: 5.85
Short Term on a couple of bits of good news 25p.With Approval 50p.Commercialisation/Partnership +70p.
Price: 5.70
Hold
Don't forget that a deal for commercialisation may have been agreed, but relies on FDA approval.Which we think will happen, but we thought that in February.
Price: 7.00
HanibalCan you link to where this information is written down, ie released from the company.Thanks in advance.
Price: 7.35
Nasdaq are in batches of 25, so $7 is equivalent to approx 20p i think.
Price: 10.12
It will be interesting to see what Sand Grove have done. (held, Sold or Increased)I was assuming a takeover on approval, is that more or less likely now?
Price: 6.00
Offered 5p.What percentage of CRL then go on to be approved, does anybody know?Apologize to petch, seem to have been right all along.
Price: 40.40
He's not a Patch on last de-ramper.
Price: 39.30
Significant holdershttps://www.motifbio.com/aim-investors/share-information/Should be up to date.
Price: 41.50
Why have the Autos repeatedly taken the SP down for what? a year and a half.You wouldn't want to keep the price down of something you didn't want to buy.
I have no idea what he's said, as filtered.All will become clear this week.
Login failed